MENU
+Compare
MGRM
Stock ticker: NASDAQ
AS OF
Jun 17 closing price
Price
$2.88
Change
+$0.08 (+2.86%)
Capitalization
73.39M

MGRM Monogram Orthopaedics Forecast, Technical & Fundamental Analysis

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging... Show more

MGRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MGRM with price predictions
Jun 17, 2025

MGRM in +8.27% Uptrend, advancing for three consecutive days on June 17, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MGRM advanced for three days, in of 105 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 09, 2025. You may want to consider a long position or call options on MGRM as a result. In of 40 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MGRM just turned positive on June 09, 2025. Looking at past instances where MGRM's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .

MGRM moved above its 50-day moving average on June 13, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for MGRM crossed bearishly below the 50-day moving average on May 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MGRM broke above its upper Bollinger Band on June 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MGRM entered a downward trend on June 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.479) is normal, around the industry mean (24.307). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (142.857) is also within normal values, averaging (42.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MGRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
MGRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MGRM is expected to report earnings to rise 10.00% to -10 cents per share on August 13

Monogram Orthopaedics MGRM Stock Earnings Reports
Q2'25
Est.
$-0.11
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.06
Q2'24
Est.
$-0.11
The last earnings report on May 14 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 80.35K shares outstanding, the current market capitalization sits at 73.39M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
3913 Todd Lane
Phone
+1 512 399-2656
Employees
28
Web
https://www.monogramorthopedics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNMAH10.22N/A
N/A
Fannie Mae
MAUTF3.37-0.01
-0.44%
Montage Gold Corp.
HDLMY40.74-0.60
-1.45%
HEIDELBERG MATERIALS AG
TWODY16.34-0.25
-1.51%
Taylor Wimpey Plc
CRARY9.08-0.17
-1.84%
Credit Agricole SA

MGRM and Stocks

Correlation & Price change

A.I.dvisor tells us that MGRM and CLPT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MGRM and CLPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGRM
1D Price
Change %
MGRM100%
+2.86%
CLPT - MGRM
32%
Poorly correlated
-3.71%
STXS - MGRM
28%
Poorly correlated
+4.61%
TWST - MGRM
27%
Poorly correlated
-3.20%
ICUI - MGRM
26%
Poorly correlated
-2.45%
HYPR - MGRM
25%
Poorly correlated
-2.15%
More

Groups containing MGRM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGRM
1D Price
Change %
MGRM100%
+2.86%
Medical Specialties
industry (393 stocks)
24%
Poorly correlated
-0.97%
Medical Specialties
industry (423 stocks)
24%
Poorly correlated
-1.04%